These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 6717750)

  • 1. Modulation of luteinizing hormone release and catecholamine activity by opiates in the female rat.
    Adler BA; Crowley WR
    Neuroendocrinology; 1984 Mar; 38(3):248-53. PubMed ID: 6717750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex differences in the responses of hypothalamic luteinizing hormone-releasing hormone and catecholamine systems to ovarian hormones and naloxone: implications for sexual differentiation of luteinizing hormone secretion in rats.
    Crowley WR
    Brain Res; 1988 Oct; 461(2):314-21. PubMed ID: 3052697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for gamma-aminobutyric acid modulation of ovarian hormonal effects on luteinizing hormone secretion and hypothalamic catecholamine activity in the female rat.
    Adler BA; Crowley WR
    Endocrinology; 1986 Jan; 118(1):91-7. PubMed ID: 3510124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of morphine on luteinizing hormone secretion and catecholamine turnover in the hypothalamus of estrogen-treated rats.
    Akabori A; Barraclough CA
    Brain Res; 1986 Jan; 362(2):221-6. PubMed ID: 3942873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sexual maturation modifies the catecholaminergic control of gonadotrophin secretion and the effect of ovarian hormones on hypothalamic neurotransmitters in female rats.
    Moguilevsky JA; Arias P; Szwarcfarb B; Carbone S; Rondina D
    Neuroendocrinology; 1990 Oct; 52(4):393-8. PubMed ID: 1702190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of naloxone on catecholamine and LHRH release from the perifused hypothalamus of the steroid-primed rat.
    Leadem CA; Crowley WR; Simpkins JW; Kalra SP
    Neuroendocrinology; 1985 Jun; 40(6):497-500. PubMed ID: 3892353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of estradiol and progesterone on catecholamine turnover rates in discrete hypothalamic regions in ovariectomized rats.
    Wise PM; Rance N; Barraclough CA
    Endocrinology; 1981 Jun; 108(6):2186-93. PubMed ID: 6785074
    [No Abstract]   [Full Text] [Related]  

  • 8. Catecholamine mechanisms in the feedback effects of estradiol benzoate on the release of LH and prolactin.
    Tobias H; Carr LA; Voogt JL
    Proc Soc Exp Biol Med; 1983 Nov; 174(2):284-90. PubMed ID: 6356136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catecholestrogens affect catecholamine turnover rates in the anterior part of the mediobasal hypothalamus and medial preoptic area in the male and female castrated rat.
    Parvizi N; Wuttke W
    Neuroendocrinology; 1983; 36(1):21-6. PubMed ID: 6828204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of estrogen and progesterone on plasma gonadotropins and on catecholamine levels and turnover in discrete brain regions of ovariectomized rats.
    Crowley WR; O'Donohue TL; Wachslicht H; Jacobowitz DM
    Brain Res; 1978 Oct; 154(2):345-57. PubMed ID: 210888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of morphine administration on catecholamine levels in rat brain; specific reduction of epinephrine concentration in hypothalamus.
    Ota M; Mefford IN; Naoi M; Linnoila M
    Neurosci Lett; 1991 Jan; 121(1-2):129-32. PubMed ID: 2020369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that norepinephrine and epinephrine systems mediate the stimulatory effects of ovarian hormones on luteinizing hormone and luteinizing hormone-releasing hormone.
    Adler BA; Johnson MD; Lynch CO; Crowley WR
    Endocrinology; 1983 Oct; 113(4):1431-8. PubMed ID: 6352246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of naloxone and morphine on LH and prolactin release in androgen-sterilized rats.
    Petersen SL; Barraclough CA
    Neuroendocrinology; 1986; 44(1):84-8. PubMed ID: 3785576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catecholamine turnover rates in discrete hypothalamic areas and associated changes in median eminence luteinizing hormone-releasing hormone and serum gonadotropins on proestrus and diestrous day 1.
    Rance N; Wise PM; Selmanoff MK; Barraclough CA
    Endocrinology; 1981 May; 108(5):1795-802. PubMed ID: 6783392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective actions of prolactin on catecholamine turnover in the hypothalamus and on serum LH and FSH.
    Gudelsky GA; Simpkins J; Mueller GP; Meites J; Moore KE
    Neuroendocrinology; 1976; 22(3):206-15. PubMed ID: 1028951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of catecholaminergic systems in the zona incerta in the steroidal control of gonadotrophin release and female sexual behaviour.
    Wilson CA; James MD; Grierson JP; Hole DR
    Neuroendocrinology; 1991 Feb; 53(2):113-23. PubMed ID: 1901630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of cholinergic nicotine-like receptors as modulators of amine turnover in various types of hypothalamic dopamine and noradrenaline nerve terminal systems and of prolactin, LH, FSH and TSH secretion in the castrated male rat.
    Andersson K; Fuxe K; Eneroth P; Agnati LF
    Acta Physiol Scand; 1982 Sep; 116(1):41-50. PubMed ID: 6818838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epinephrine synthesis inhibitors block naloxone-induced LH release.
    Kalra SP; Crowley WR
    Endocrinology; 1982 Oct; 111(4):1403-5. PubMed ID: 7117202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the serotonin agonist, quipazine, on luteinizing hormone and prolactin release: evidence for serotonin-catecholamine interactions.
    Lynch CO; Johnson MD; Crowley WR
    Life Sci; 1984 Oct; 35(14):1481-7. PubMed ID: 6148678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for hypothalamic noradrenergic involvement in naloxone-induced stimulation of luteinizing hormone release.
    Van Vugt DA; Aylsworth CF; Sylvester PW; Leung FC; Meites J
    Neuroendocrinology; 1981 Nov; 33(5):261-4. PubMed ID: 7301047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.